Irisin is elevated in type 2 diabetes and is associated with elevated levels of E-selectin; therefore, irisin may constitute a potential new therapeutic opportunity in the areas of obesity and diabetes [3]. This evidence concerns the gene FNDC5 and obesity due to melanocortin 4 receptor deficiency.